Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 5788-5795, October 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uckun, F. M.
Right arrow Articles by Song, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uckun, F. M.
Right arrow Articles by Song, C. W.

Radiobiological Features of Fresh Leukemic Bone Marrow Progenitor Cells in Acute Lymphoblastic Leukemia1

Fatih M. Uckun2 and Chang W. Song

Departments of Therapeutic Radiology-Radiation Oncology/Tumor Immunology Laboratory [F. M. U., C. W. S.], Department of Pediatrics [F. M. U.], and the Bone Marrow Transplantation Program [F. M. U.], University of Minnesota Health Sciences Center, Minneapolis, Minnesota 55455

The radiobiological features of leukemic progenitor cells (LPC) freshly obtained from 14 T-lineage acute lymphoblastic leukemia (ALL) and 11 B-lineage ALL patients were evaluated using LPC colony assays. No significant radiobiological differences were observed between T-lineage versus B-lineage ALL LPC. Notably, the D0 values displayed a significant interpatient variation in both groups, indicating a pronounced heterogeneity in the radiation sensitivity of LPC. LPC from some patients were very radioresistant, and in additional experiments using cryopreserved bone marrow blasts, up to 32% of LPC could survive 1600 cGy delivered at 100 cGy/min. In six of 11 T-lineage ALL cases and five of ten B-lineage ALL cases, a distinct initial shoulder was present on the single dose radiation survival curves, providing circumstantial evidence that LPC are able to repair sublethal radiation damage. A greater proportion of LPC survived 400 cGy when the dose was delivered in two fractions instead of a single dose, providing direct evidence that LPC in ALL possess a substantial capacity to repair sublethal radiation damage. The interpatient differences in D0 and recovery factor values indicated a marked heterogeneity in the ability of LPC to repair sublethal radiation damage. Analysis of the dose rate effects on the radiation survival of LPC in four ALL cases suggested that the radiation sensitivity of LPC is dose rate dependent. Normal bone marrow progenitor cells (colony-forming unit, granulocyte-macrophage, and burst-forming unit, erythroid) were more radiosensitive and unable to repair sublethal radiation damage. To our knowledge, this report represents (a) the first detailed comparative analysis of the radiobiological features of freshly obtained LPC in T-lineage and B-lineage ALL patients, and (b) the first elucidation of radiobiological differences between leukemic ALL versus normal bone marrow progenitor cells.

1 Supported in part by USPHS Grants R29-CA-42111, R01-CA-42633, and P01-CA-21737 awarded by the National Cancer Institute, Department of Health and Human Services, and a Special Grant from the Minnesota Medical Foundation. This is Publication 15 from the Tumor Immunology Laboratory, University of Minnesota. Presented in part at the 29th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology, Boston, MA, October 18–23, 1987.

2 Recipient of a FIRST Award from the NIH and Special Fellow of the Leukemia Society of America. To whom requests for reprints should be addressed, at Box 356 UMHC, Tumor Immunology Laboratory, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN 55455.

Received 2/15/88. Revised 6/24/88. Accepted 7/ 6/88.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
F. M. Uckun, P. S. Gaynon, D. O. Stram, M. G. Sensel, M. B. Sarquis, K. H. Lazarus, and M. Willoughby
Paucity of Leukemic Progenitor Cells in the Bone Marrow of Pediatric B-Lineage Acute Lymphoblastic Leukemia Patients with an Isolated Extramedullary First Relapse
Clin. Cancer Res., September 1, 1999; 5(9): 2415 - 2420.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. M. Uckun, L. Tuel-Ahlgren, K. G. Waddick, X. Jun, J. Jin, D. E. Myers, R. B. Rowley, A. L. Burkhardt, and J. B. Bolen
Physical and Functional Interactions between Lyn and p34[IMAGE] Kinases in Irradiated Human B-cell Precursors
J. Biol. Chem., March 15, 1996; 271(11): 6389 - 6397.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.